Golden Developing Solutions, Inc.
Golden Developing Solutions, Inc.
Your view on DVLP
Overview
What the company does, where it operates, and who runs it.
About Golden Developing Solutions, Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Stavros A. Triant
- Headquarters
- PO Box 460573, Fort Lauderdale, FL, US
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Stavros A. Triant
- Headquarters
- PO Box 460573, Fort Lauderdale, FL, US
Golden Developing Solutions, Inc., together with its subsidiaries, engages in developing an online retail business for cannabidiol (CBD) products. It develops and operates an Internet website that offers CBD, hemp oil, and health/wellness related products, including vitamins, supplements, CBD based tinctures, vapes, soft-gels, and other products.
The company was formerly known as Clean Hydrogen Producers, Ltd and changed its name to Golden Developing Solutions, Inc. in April 2017. Golden Developing Solutions, Inc. was incorporated in 1998 and is based in Fort Lauderdale, Florida.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Golden Developing Solutions, Inc., and the rating behind it. DVLP last traded at $0.0000; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Golden Developing Solutions, Inc.. Starting points for Golden Developing Solutions, Inc.: beta 46.71 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Golden Developing Solutions, Inc.. Golden Developing Solutions, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Golden Developing Solutions, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Golden Developing Solutions, Inc.. Golden Developing Solutions, Inc. has reported as a listed company since 2016. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Golden Developing Solutions, Inc. valued side by side against its closest peers. Golden Developing Solutions, Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Golden Developing Solutions, Inc., and how their positions are changing. At a $14,135 market value, institutional positions materially move Golden Developing Solutions, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Golden Developing Solutions, Inc. executives and directors. Shares of Golden Developing Solutions, Inc. have traded between $0.0000 and $0.0001 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Golden Developing Solutions, Inc.. Golden Developing Solutions, Inc. is a $14,135 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Golden Developing Solutions, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Golden Developing Solutions, Inc.. Coverage tracks Golden Developing Solutions, Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.